Coning v. Bayer Pharma AG et al (PLR1)
| Coning and Abra L. Coning |
| Bayer Pharma AG(PLR1), Bayer Pharma AG, Bayer Oy and Bayer Healthcare Pharmaceuticals Inc. |
| 1:2017cv02674 |
| April 13, 2017 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| James L Cott |
| Paul A Engelmayer |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 pl Diversity-Product Liability |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 21, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 138
CLERK'S JUDGMENT re: (66 in 1:17-cv-02883-PAE-JLC, 63 in 1:17-cv-02866-PAE-JLC, 78 in 1:17-cv-02792-PAE-JLC, 67 in 1:17-cv-02798-PAE-JLC, 137 in 1:17-cv-02674-PAE-JLC, 78 in 1:17-cv-02854-PAE-JLC, 69 in 1:17-cv-02853-PAE-JLC, 77 in 1:17-cv-02791-PAE-JLC, 76 in 1:17-cv-02738-PAE-JLC, 84 in 1:17-cv-02737-PAE-JLC, 63 in 1:17-cv-02891-PAE-JLC, 68 in 1:17-cv-02856-PAE-JLC, 68 in 1:17-cv-02821-PAE-JLC, 66 in 1:17-cv-02895-PAE-JLC, 61 in 1:17-cv-02861-PAE-JLC, 79 in 1:17-cv-02745-PAE-JLC, 74 in 1:17-cv-02724-PAE-JLC, 74 in 1:17-cv-02887-PAE-JLC, 69 in 1:17-cv-02807-PAE-JLC, 63 in 1:17-cv-02865-PAE-JLC, 347 in 1:17-md-02767-PAE-JLC, 75 in 1:17-cv-02721-PAE-JLC, 72 in 1:17-cv-02826-PAE-JLC, 78 in 1:17-cv-02794-PAE-JLC, 81 in 1:17-cv-02718-PAE-JLC, 72 in 1:17-cv-02790-PAE-JLC, 73 in 1:17-cv-02814-PAE-JLC, 79 in 1:17-cv-02741-PAE-JLC, 71 in 1:17-cv-02878-PAE-JLC, 70 in 1:17-cv-02811-PAE-JLC, 79 in 1:17-cv-02719-PAE-JLC, 68 in 1:17-cv-02819-PAE-JLC, 82 in 1:17-cv-02781-PAE-JLC, 79 in 1:17-cv-02797-PAE-JLC, 85 in 1:17-cv-02715-PAE-JLC, 68 in 1:17-cv-02812-PAE-JLC, 73 in 1:17-cv-02851-PAE-JLC, 71 in 1:17-cv-02816-PAE-JLC, 81 in 1:17-cv-02778-PAE-JLC, 68 in 1:17-cv-02827-PAE-JLC, 122 in 1:17-cv-02694-PAE-JLC, 98 in 1:17-cv-02698-PAE-JLC, 70 in 1:17-cv-02874-PAE-JLC, 91 in 1:17-cv-02705-PAE-JLC, 68 in 1:17-cv-02872-PAE-JLC, 55 in 1:17-cv-02692-PAE-JLC) Memorandum & Opinion,,. in favor of Bayer Healthcare Pharmaceuticals Inc, Bayer Healthcare Pharmaceuticals Inc., Bayer Healthcare Pharmaceuticals Inc.,, Bayer Healthcare Pharmaceuticals, Inc., Bayer Oy, Bayer Pharma AG, Bayer healthcare pharmaceuticals, inc. against Abigail Michel, Abigail Thiesing, Abra Coning, Abra L. Coning, Adam Klopfenstein, Adrian Clark, Adrienne Seuzeneau, Aida Lozada, Aimee Galloway, Aisha Cuffie, Aislynn Pounds, Alaina Dice, Alana Sirmans, Alecia Conner, Alecia Henry, Aleta Brek Richards, Alexandra Haines, Alexandria Estrada, Alexis Gallien, Alexis Walton, Alfreda Bolden, Alicia Ruffin, Alicia Thames, Alinkie Joseph, Alisha Scudder, Alison Ashcroft, Aliya Quick, Allison Simpson, Alyssa Johnson, Alysta Espinal, Alyxis Feltus, Amanda Clark, Amanda Crites, Amanda Evans, Amanda Garcia, Amanda Goodlet, Amanda Harvey, Amanda Massie, Amanda Pichla, Amanda Sailors, Amanda Santoro, Amanda Stevens, Amanda Waite, Amanda Wilson, Amanda Wolters, Amanda Leeann Barber, Amber Brueggert, Amber Fennell, Amber Hanson, Amber Hoda, Amber Large, Amber Ostermiller-Ecord, Amber Darlene Prout, Amber R. Dryden, Amberly Buckner, Amelia Holman Miles, Amy Ammons, Amy Cholewinski, Amy Edwards, Amy Hodge, AnJanet Coleman, Anais Forcier, Analycia Sanchez, Andrea Bruno, Andrea Easter, Andrea Gee, Andrea Johnson, Andrea Lucero, Andrea Martinez, Andrea Novak, Andrea Robinson, Andrea Vega, Andria Reed, Angela Henderson, Angela Klopfenstein, Angela Kolebuck Utz, Angela Norred, Angela Robinson, Angela Schneider, Angela Rose Padilla, Angelina Sharidan, Angeline Stanger, Angell Navarre, Anisha Longmire, Anita Long, Anitra Wade, Ann Everett, Anna Conley, Annalissa Sanchez, Anne Guillot, Anne Wilson, April Galloway, April Johnson, April Robertson, Arielle Catron, Arin Boehmer, Arlene Cordero, Arrielle Hughes, Asha' Ana Thomas, Ashley Antkowiak, Ashley Babich-Zacharias, Ashley Davis, Ashley Mandoline, Ashley McCune, Ashley McLuckie, Ashley Nobles-Hobbs, Ashley Pearson, Ashley Rodriguez, Ashley Steed, Ashli Garner, Ashly Amber Cockrell, Ashlyn Hackworth-Williams, Ashton Silvis, Asia Shakespeare, Audrey Joines, Barbara Anderson, Barbara Napier, Bernesha Means, Bess Patterson, Beth Burton, Bethany Vincent, Betty Wempe, Billy Cheek, Bonnie Cedano, Brandi Carroll, Brandi Favors, Brandi Geddings, Brandy Fletcher, Brayanne Ford, Breanna Pieters, Breanna Williams, Brenda Yearout, Briana Garner, Briana McCranie, Briana Stills, Brianna Blackman, Brianna Peters, Brianna Smith, Brianne Trigger, Bridget Coburn, Bridgette Blunt, Brigette Morris, Brigitte Cockcroft, Britney Murphy, Britney Thompson, Brittany Collins, Brittany Greco, Brittany Harsch, Brittany Shumpert, Brittany Thomas, Brittany Watkins, Brittany Wilson, Brittany Nicole James, Brittany S. Smith, Brittney M. Gentry, Brooke Birge, Caitlyn Aboulba, Callie Jordan, Candace Crovetto, Candice Arnwine, Candice Bailey, Candice Small, Carla Walcott, Carley Hamilton, Carmen Morales, Carneshia Cason, Carol Jackson, Carolina Romero, Carolyn Sutton, Carrie Breaux, Carrie Thompson, Cassandra Becker, Cassandra N Johnson, Catherine Andrade, Catherine Godfrey, Catherine Jensen, Catherine King, Catherine Martinez, Catherine Dianne Beitel, Catie Kessler, Chandra Brown, Chandra Mason, Chanell Winn, Chanthinia White, Chaquita Dudley, Charla Myers-Perkins, Charlene Gomez, Charles Monet, Charlotte Brown, Charlotte Stribling, Charmina Lewis, Chassidy Fruge, Chavon Plange, Cheetarr Jackson, Chelsea Coulter, Chelsea Van Wert, Chelsea M. Sawyer, Chelsea Marie Bryant, Chelsey Baudoin, Cherie Mcgee, Cheryl Danielle Brodfehrer, Chessica Maus, Cheylo Collado, Christa Diehl, Christal Baugh, Christi Utley, Christie Epperly, Christina Holland, Christina Ray, Christina Reid, Christine Wilson, Christon Fore, Christopher Barlow, Christy Nicole Mcgregor, Christy S. Murphy, Chyneice Oliver, Ciara Hayes, Ciera Cole, Ciera Lamb, Ciera Turner, Cierra Denise Garner, Cindel Downs, Cindy N. Best, Clara Allen, Clarity Pavon-Moore, Conica Winston, Constance Steele, Cora Clear, Corneisha Foster, Cortnie Short, Cosette Posorski, Courtney Smith, Courtney Trennepohl, Crystal Barlow, Crystal Covert, Crystal Rodgers, Crystal Taylor, Crystal Vazquez, Cynthia Gunn, Cynthia Munro, Daffney Hicks, Dalia Jasso, Dana Y Cooper, Danica Hendricks, Daniel Bourgoin, Daniel Parsons, Daniella Pavelka, Danielle Adams, Danielle Butler, Danielle Holt, Danielle Korte, Danielle Schmidt, Danielle Wehrley, Danise Hoffman, Danyell Russell, Daphne Franklin, Daphne Houck, Darnesia Finkley, David Burns, David Rodriguez, Davita Robinson, Dawn Breen, DeShera Myers, Deanna Mooney, Delilah Perez, Denise Ancar, Denise Ford, Denise Keiderling, Deshaunna Johnson, Deshonda Knight, Desiree Lemaster, Desiree Saenz, Detra Ferguson, Devina Williams, Devon Mahlstedt, Devon Parker, Devon Pinckney, Dewayna Denille Brown, Diana Leonard, Dodie Arnold, Donisha Bishop, Donisha Butler, Donna Harris, Donna Rawdon, Doretha Smith, Dorionne Huntington, Dyonche Willis, Ebonee Richardson, Eboni Shaw, Ebony Ray, Ebony Taylor, Elizabeth Adams, Elizabeth Bryce, Elizabeth Damron, Elizabeth Heagy, Elizabeth Montanaro, Elizabeth Olson, Elizabeth Paige, Elizabeth K. Moore, Ellen Burns, Emilie Sitzman, Emillie Hopper, Emily Cokrlic, Emily Springer, Erendira Cuevas, Erica Owens, Erica Rodriguez, Erica Silva, Erica Smith, Erica Williams, Ericka Jones-George, Ericka Turner, Erika Claiborne, Erika Nacke, Eshia Davis, Eve Sims, Faith Law, Fallon Evans, Felita Dooley, Flora Jordan, Freddrekia Bradley, Gabrielle Hoffman, Gashia Williams, Gembelle Horlacher, Georgia Foster, Gina Baker, Ginger Kuchler, Gloria Fields, Gloribi Pastor, Grace Dixon, Graceann Robinson, Guadalupe Pineda, Hailey Shelton, Haley Henn, Hannah Rutledge, Hattie Hansen, Heather Baker, Heather Cruver, Heather Garcia, Heather Hemberger, Heather Kuramoto, Heather Nicolle Mcmullan, Heather Onsum Stoops, Heidi Rosenow, Heidi Thomas, Hillery Thompson, Holly Allen, Holly Jones, Hope Garcia, Hope Gayle, Ieacha Jackson, Ingrid Bustos, Jaclyn Herald, Jaclyn Spett, Jacob Roseland, Jacqueline Goyena, Jacqueline Sherley-Douglas, Jacquelyn Seifert, Jade A. Ludwikowski, Jaime Peller, Jaime Powell, Jalisa Crapo, James Esparza, Jami Olson, Jamie O'Bryan, Jamie Whitely, Jamisha Dyer, Janeka Haynes, Janell Davis, Janelle Pallansch, Jasman Al-Shwaiyat, Jasmin Thurman, Jasmine Baynham, Jasmine Howard, Jasmine Lefort, Jasmine Short, Jayde Seaford, Jeanie Lascelles, Jefkida Johnson-Stinson, Jena Cook, Jenna True, Jennifer Baxter, Jennifer Draughn, Jennifer Drayton, Jennifer Ducre, Jennifer Gibliant, Jennifer Guzdek, Jennifer Hull, Jennifer Legassie, Jennifer Sand-Shequen, Jennifer Santiago, Jennifer Sisson, Jennifer Sullivan, Jennifer Ure, Jennifer Lynn Carr-Amonett, Jeralyn Wiley, Jeresa Morgan, Jerica Schaffer, Jerrelda Sanders, Jerry Jane Wynne, Jessica Bihler, Jessica Cash, Jessica Crouse, Jessica Fuller, Jessica Gardner, Jessica Grabill, Jessica Guglielmo, Jessica Hupman, Jessica Jefferson, Jessica Jett, Jessica Kilbourne, Jessica Nieslawski, Jessica Oqueli, Jessica Roberson, Jessica Roseland, Jessica Stanley, Jessica Watson, Jessica Wein, Jessica White, Jessica Hixson Robinson, Jessica Lynn Simmons, Jessica Marie Peterson, Jessika Allen, Jetta Allen, Jevon Bogan, Jill Genovesi, Jill Johnson, Jill Sneed, JoAn Redfield, Joanna Lynn Lucero, Joanna Momoko Cline, Jodie Swoffer, John Silva, III, Jonathan Miles, Jonel Edwards, Joshua Gentry, Joy Myers, Jozzette Randle, Juanita Figueroa, Julia Ferguson, Julia Meachem, Juliana Catarina Hernandez, Julie Garcia, Julie Gonzalez, Julie LaVigne, Julie Nelson, Julie Spencer, Kaitlin Stringfellow, Kaitlyn Sklenar, Kalena Williams, Kamille Turnbow, Kaqante Brown, Kara Stanley, Kareama Patterson, Karen Crear, Karen Francis, Karla M. Duelley, Karlena Jenks, Karna Lynne Pettlon, Karrie Shields, Kasey Garrison, Kasey Jackson, Kassandra Halstead, Kate Jensen, Katelyn Tower, Katelynn Hammond, Katharine Wells, Katherine Jacobsen, Katherine Sotelo, Kathleen Cheek, Kathleen Fox, Kathleen Frizzell, Kathleen Huerta, Kathleen Molina, Kathleen Renata Seegers, Kathleena Hays, Kathryn Asbel, Kati Valentine, Katie Arabie, Katie Decker, Katie Myers, Katie Schubel, Katie Lynn Arabie, Katie Rebecca Lawrence, Katomia Morris, Katrena Warr, Katrice Roussell, Katrina Everett-Carey, Katrina Stevenson, Kay Page, Kayla Clayton, Kayla Faulkner, Kayla Owens, Kayla Scott, Kayla Talley, Kaytlin Raines, Keionne Thompson, Keisha Currie, Keisha Pierce, Keisha Seward, Kelli Salazar, Kelli Boyt Rowland, Kelly Casnave, Kelly Cichetti, Kelly Harrigan, Kelly Kennedy, Kelly Reis, Kelly Riegel-Green, Kelsey Harris, Kelsey Jackson, Kelsey Ramm, Kemisha Wilder, Kendra Hill, Kendra Patterson, Kendra Wickware, Keona Burton, Keri Rice, Keshia Barnette, Keysa Ellis, Keyshara Armstead, Khadijah Robinson, Khalilah Bowens, Khelee Sawyer, Kia Barnes, Kiera McC
|
|
Filing 137
OPINION & ORDER re: (328 in 1:17-md-02767-PAE-JLC) MOTION for Summary Judgment filed by Bayer Oy, Bayer Pharma AG, Bayer Healthcare Pharmaceuticals Inc. For the reasons stated above, Bayer's motion for summary judgment is granted. The Clerk of Court is respectfully directed to terminate the pending motion (No. 17 MD 2767, Dkt. 328), and to enter judgment in and close all remaining member cases in this MDL. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 6/11/2019) **Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc) Transmission to Orders and Judgments Clerk for processing.
|
|
Filing 136
OPINION & ORDER re: (328 in 1:17-md-02767-PAE-JLC) MOTION for Summary Judgment filed by Bayer Oy, Bayer Pharma AG, Bayer Healthcare Pharmaceuticals Inc. For the reasons stated above, Bayer's motion for summary judgment is granted. The Clerk of Court is respectfully directed to terminate the pending motion (No. 17 MD 2767, Dkt. 328), and to enter judgment in and close all remaining member cases in this MDL. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 6/11/2019) **Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc) Transmission to Orders and Judgments Clerk for processing.
|
|
Filing 135
ORDER granting (343) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-md-02767-PAE-JLC; granting (134) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02674-PAE-JLC; granting (119) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02694-PAE-JLC; granting (88) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02705-PAE-JLC; granting (82) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02715-PAE-JLC; granting (78) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02718-PAE-JLC; granting (81) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02737-PAE-JLC; granting (76) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02745-PAE-JLC; granting (65) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02812-PAE-JLC; granting (73) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02813-PAE-JLC; granting (70) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02814-PAE-JLC; granting (68) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02816-PAE-JLC; granting (65) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02819-PAE-JLC; granting (65) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02821-PAE-JLC; granting (69) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02826-PAE-JLC; granting (65) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02827-PAE-JLC; granting (58) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02861-PAE-JLC; granting (60) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02865-PAE-JLC; granting (60) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02866-PAE-JLC; granting (60) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02891-PAE-JLC; granting (131) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02900-PAE-JLC; granting (113) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02916-PAE-JLC; granting (62) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02943-PAE-JLC; granting (55) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02945-PAE-JLC; granting (137) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02947-PAE-JLC; granting (57) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02950-PAE-JLC; granting (64) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02952-PAE-JLC; granting (63) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02961-PAE-JLC; granting (63) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02962-PAE-JLC; granting (64) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02992-PAE-JLC; granting (75) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02993-PAE-JLC; granting (57) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-02994-PAE-JLC; granting (56) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03067-PAE-JLC; granting (58) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03068-PAE-JLC; granting (58) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03069-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03072-PAE-JLC; granting (55) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03074-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03080-PAE-JLC; granting (55) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03083-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03084-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03085-PAE-JLC; granting (56) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03087-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03088-PAE-JLC; granting (55) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03124-PAE-JLC; granting (192) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03125-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03143-PAE-JLC; granting (54) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03146-PAE-JLC; granting (56) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03147-PAE-JLC; granting (53) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03216-PAE-JLC; granting (53) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03219-PAE-JLC; granting (84) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03231-PAE-JLC; granting (155) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03233-PAE-JLC; granting (78) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03236-PAE-JLC; granting (99) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03238-PAE-JLC; granting (83) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03240-PAE-JLC; granting (88) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03242-PAE-JLC; granting (76) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03298-PAE-JLC; granting (50) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03334-PAE-JLC; granting (50) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03335-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03354-PAE-JLC; granting (51) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03390-PAE-JLC; granting (50) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03497-PAE-JLC; granting (50) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-03499-PAE-JLC; granting (56) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04301-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04579-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04581-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04582-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04583-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04584-PAE-JLC; granting (45) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04597-PAE-JLC; granting (41) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04967-PAE-JLC; granting (42) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-04981-PAE-JLC; granting (35) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05090-PAE-JLC; granting (35) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05138-PAE-JLC; granting (41) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05335-PAE-JLC; granting (41) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05338-PAE-JLC; granting (41) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05345-PAE-JLC; granting (35) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05762-PAE-JLC; granting (35) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-05763-PAE-JLC; granting (77) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-06638-PAE-JLC; granting (29) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-06714-PAE-JLC; granting (31) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-07149-PAE-JLC; granting (28) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-07447-PAE-JLC; granting (28) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-07449-PAE-JLC; granting (25) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-07877-PAE-JLC; granting (23) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-08399-PAE-JLC; granting (25) Motion to Withdraw as Attorney. Attorney Christina T. Natale terminated in case 1:17-cv-08479-PAE-JLC; granting (25) Motion to Withdraw as Attorney. A
|
|
Filing 134
MOTION for Christina T. Natale to Withdraw as Attorney . Document filed by Amanda Waite, Christy Nicole Mcgregor, Alexandria Estrada, Jessica Cash, LaToya S. Thompson, Jessica Roseland, Jacob Roseland, Maria Pitts, Jessica Marie Peterson, Amanda Harvey, Jetta Allen, Kara Stanley, Christi Utley, Heather Kuramoto, Peterson Bridges, Shameka M Bridges, Tammi Miller, Catherine Dianne Beitel, Christa Diehl, Ashley Babich-Zacharias, Siobhan Schall, Marsha Sapp Hankins, Jacqueline Goyena, Sarah E. Lynch, Whitney Walker, David Burns, Ellen Burns(Individually and as personal representative or executrix or administratrix of the Estate of Anne Alden Burns), Laura Burns, Mary Margaret Cottingham, Abra L. Coning, Rachel Elizabeth Sammons, Chessica Maus, Sara Sutphin, Brittany Greco, Latricia Anderson Johnson, Amanda Massie, Breanna Pieters, Jennifer Lynn Carr-Amonett, Lacey Langston Sanderlin, Stephanie Sellers, Heather Onsum Stoops, Samantha Liford, Shamara Von Lane, Danielle Holt, Aleta Brek Richards, Karna Lynne Pettlon, Rachel McIntyre, Cherie Mcgee, Margaret Bender, Ashli Garner, Amber Darlene Prout, Nichole Hiller, Kasey Garrison, Heather Nicolle Mcmullan, Billy Cheek, Kathleen Cheek, Carneshia Cason, Naquasha Riser, Lauren Hardwick, Elizabeth Heagy, Kaitlyn West, Melissa Frances Hall, Gabrielle Hoffman, Krista Burke, Trudy Cole, Jonathan Miles, Amelia Holman Miles, Ashly Amber Cockrell, Jenna Gies, Chavon Plange, Amanda Leeann Barber, Stacy Beth Swenton, Elizabeth Bryce, Kayla Owens, Shane Hausner, Tiffany Hausner, Leah Fackrell, Shelby Luann McCain, Devon Mahlstedt, Kristy Collins, Leslie Marie Coapman, Kathleen Renata Seegers, Jennifer Hull, Jessica Gardner, Abigail Thiesing, Kylara Booth, Daniel Parsons, Cierra Denise Garner, Megan Robinson, Jennifer Baxter, Christal Baugh, Jasman Al-Shwaiyat, Catherine King, Stephanie Christina Albertson, Barbara Anderson, Kathryn Asbel, Jasmine Baynham, Cindy N. Best, Brianna Blackman, Kristen Denise Bryan, Ellen Burns(Individually ), Ellen Burns(As personal representative or executrix or administratrix of the Estate of Anne Alden Burns), Beth Burton, Joanna Momoko Cline, Shawna Louise Cooper, Steffanie Michelle Dennis, Jessica Guglielmo, Daphne Houck, Kasey Jackson, Abigail Michel, Jonathan Miles, Lindsay Miller, Sadie Miller, Tammi Miller, Sierra Moore, Katie Myers, Erika Nacke, Ashley Nobles-Hobbs, Kareama Patterson, Melissa Polomsky, Sonya Ramsey, Stephanie Schlueter, Kayla Scott, Kathleen Renata Seegers, Hailey Shelton, Brittany S. Smith, Ashley Steed, Stacy Beth Swenton, Melissa Tolbert, Ericka Turner, Bethany Vincent, Lamara Walker, Sarah Marie Wessel, Taquoya Keryawna Williams, Brittany Wilson, Alyssa Johnson, Crystal Vazquez, Hailey Shelton, Jasmine Baynham, Kendra Hill, Cindy N. Best, Nicole Hamill. (Attachments: #1 Text of Proposed Order)Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al.(Natale, Christina)
|
|
Filing 133
ORDER: The Court directs counsel promptly to meet and confer as to next steps in this multi-district litigation. The Court asks counsel to consider whether, as in the earlier multi-district litigation involving Mirena presided over by Judge Seibel, this case should now proceed to motions for summary judgment limited to the issue of general causation. A joint letter, setting forth the parties' proposal(s) as to next steps, is due Friday, November 9, 2018. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 10/24/2018)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 132
OPINION & ORDER re: (134, 136, 138, 141, 143, 145, 147, 149, 151, 153, 155,158, 160, 162, 165, 168, 170, 172, and 175 1:17-md-02767-PAE-JLC) MOTIONS to exclude testimony filed by Bayer Oy, Bayer Pharma AG, Bayer Healthcare Pharmaceuticals Inc. For the foregoing reasons, the Court grants Bayer's motion to exclude the testimony of plaintiffs' seven general-causation witnesses, and denies, as potentially moot, plaintiffs' motions to exclude Bayer's 12 general-causation witnesses. The Clerk of Court is respectfully directed to terminate the motions pending at Dkts. 134, 136, 138, 141, 143, 145, 147, 149, 151, 153, 155, 158, 160, 162, 165, 168, 170, 172, and 175. An order as to next steps in this case will follow shortly. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 10/24/2018) **Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc) Modified on 10/24/2018 (anc).
|
|
Filing 131
MOTION for Robert J. Binstock to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Brianna Smith. (Attachments: #1 Affidavit, #2 Text of Proposed Order, #3 Supreme Court of Texas- Certificate of Good Standing, #4 Texas State Bar- Certificate of Good Standing)Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al.(Binstock, Robert)
|
|
Filing 130
ORDER: On April 9, 2018, the Court will hold "Science Day" to provide the Court with an overview of the medical, scientific, and epidemiological issues associated with the Mirena intrauterine device and intracranial hypertension in an objective format without advocacy. As previously reviewed with counsel, the Court intends Science Day to proceed in the following manner: as set forth herein. The Court has allotted the full day of April 9, 2018 for Science Day. Proceedings will begin at 9 a.m. and will include an hour-long break for lunch, and comfort breaks in the mid-morning and mid-afternoon. Court will adjourn by 5 p.m. For the parties' planning purposes, each side is allocated at least two hours in which to present. Plaintiffs will present first, and defendants will present second. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 3/30/2018) Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al.(ama)
|
|
Filing 129
ORDER: Argument on the parties' Daubert motions is scheduled for April 10 and 11 and, if necessary, April 12, 2018. Argument each day will begin at 9 a.m. There will be an hour-long lunch break. The Court expects to adjourn each day at 5 p.m. On March 23, 2018, the parties proposed a sequence as to the topics to be covered at argument. See Dkt. 151. The Court hereby approves that proposed sequence. The Court does not, however, adopt the rigid allocation of 30 minutes time for argument as to each expert, as individual experts may merit more or less time. For avoidance of doubt, the Court is persuaded that argument is merited on both sides' Daubert motions-those directed at plaintiffs' experts and those directed at Bayer's experts. While the Court is hopeful that argument will be completed by the end of the day on April 11, 2018, the parties are to continue to reserve April 12, 2018 in the event that additional time is needed. SO ORDERED., ( Oral Argument set for 4/10/2018 at 09:00 AM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 3/30/2018) Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al.(ama)
|
|
Filing 128
ORDER: The Court has reviewed the parties' joint letter (Dkt. 130) setting forth the parties' alternative proposals for the format of the April 9 Science Day proceedings. The Court's views are as follows: The Court does not wish to hear from counsel on Science Day. The purpose of Science Day is to educate the Court about scientific and medical matters, to assist the Court in understanding the science of medicine relevant to this overall case. The Court instead wishes to hear expert presentations, i.e., by physician(s) and/or scientist(s). The Court envisions that such presentations would each take the form of an expert tutorial/lecture as to background scientific questions, supported by a Power Point and/or other demonstrative visuals; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 2/28/2018)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 127
ORDER with respect to (129) Motion to Dismiss in case 1:17-md-02767-PAE-JLC. The Court has received Bayer's motion to dismiss without prejudice for failure to submit a plaintiff fact sheet. See Dkt. 129. Pursuant to CMO 12 VI, paragraph 18, there is no action for the Court to take at this time. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 2/28/2018)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al. (anc)
|
|
Filing 126
ORDER: The Court sets a new conference on Friday, March 9, 2018 at 2:30 p.m. to discuss this plan and in particular to hear from counsel as to, inter alia, the manner in which the Science Day primer is to be conducted. The Court asks counsel to meet and confer promptly in the hope of developing jointly a plan to present a neutral primer on the relevant points. The next conference in this case, presently scheduled for Monday, February 26, 2018-which the Court had intended to use for this purpose but which can no longer so serve given that the parties opening briefs will now be filed after that date-will remain on the calendar for the time being, in the event counsel have issues to take up. The parties are to notify the Court by noon Wednesday, February 21, 2018 if they believe the conference is no longer necessary. SO ORDERED. (Status Conference set for 3/9/2018 at 02:30 PM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 2/20/2018)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 125
MEMO ENDORSEMENT on re: (120 in 1:17-md-02767-PAE-JLC) Letter filed by Bayer Oy, Bayer Pharma AG, Bayer Healthcare Pharmaceuticals Inc. ENDORSEMENT: Granted. The Court adjourns the case management conference to February 26, 2018 at 1:30 p.m. SO ORDERED. (Case Management Conference set for 2/26/2018 at 01:30 PM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 1/17/2018)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 124
ORDER: The Court has received the parties' joint letter of yesterday (Dkt. 61) proposing to adjourn the status conference scheduled for December 18, 2017, because there are no issues for the Court to resolve. The Court adjourns this conference, and commends counsel on productively working together. The Court schedules a next status conference for Friday, January 26, 2018, at 1 p.m., to be used to resolve any issues that have by then arisen, and as further set forth in this order. (Status Conference set for 1/26/2018 at 1:00 PM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 12/12/2017) Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al. and 17mc2767. (ap)
|
|
Filing 123
ORDER: The conference scheduled for Friday, December 1, 2017 is hereby adjourned. The Court schedules the next conference in this case for Monday, December 18, 2017 at 2:30 p.m. The parties are directed to file, five business days before the next conference, a joint letter informing the Court whether there are any issues ripe for resolution and if so, what the parties' respective positions on those issues are. SO ORDERED. (Status Conference set for 12/18/2017 at 02:30 PM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 11/27/2017) **Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 122
CONFIDENTIALITY AND PROTECTIVE ORDER AS TO THIRD PARTY DISCOVERY...regarding procedures to be followed that shall govern the handling of confidential material... (Signed by Judge Paul A. Engelmayer on 11/15/2017)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 121
ORDER NO. 15: IT IS HEREBY ORDERED that: Order Applicable to All Cases in MDL Proceeding. This Order shall apply to all cases currently pending in MDL No. 2767 and to all related actions that have been or will be originally filed in, transferred to, or removed to this Court and assigned thereto; and as further set forth herein. All other evidentiary objections other than authenticity are preserved. (Signed by Judge Paul A. Engelmayer on 11/7/2017)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc) . Modified on 12/8/2017 (anc).
|
|
Filing 120
ORDER: The Court has received the parties' joint letter of this morning (Dkt. 96) enumerating six topics and various sub-topics to be covered at the status conference scheduled for Wednesday, October 18, 2017. The parties' letter also indicates that on a number of different topics of subtopics, separate letters will be received by the Court from counsel. Counsels' letter does not say when the letters will be submitted. It is clear to the Court that, even if the letters were submitted by 5 p.m. today, the submission of these letters so close to the conference would not give the Court nearly enough time to meaningfully assess the parties' respective positions on the relevant issues, let alone, where practicable, to prepare bench rulings on them. At the risk of stating the obvious, it is unproductive to submit 11th-hour briefs in this manner. The parties are advised that in the future, they are to submit letters outlining positions on discovery and other disputes at least one week in advance of a scheduled conference, so as to permit the conference be maximally effective. The Court accordingly is constrained to adjourn the October 18, 2017 conference until the following week. The Court directs counsel to submit, by close of business Tuesday, October 17, 2017, all letters on the issues noted in counsels' letter of this morning. The Court will hold a status conference Tuesday, October 24, 2017, at 2:30 p.m., to take up the issues listed. Separately, counsels' letter seeks, on page 2, confirmation of counsels' shared understanding that the December 8, 2017 deposition deadline relaters only to depositions relating to the topic of general causation. The Court hereby confirms that understanding and the other understandings set out the same paragraph of counsels' letter. (Status Conference set for 10/24/2017 at 2:30 PM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 10/16/2017) Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al. (ap)
|
|
Filing 119
ORDER: The parties have notified the Court that they intend to submit a letter Monday identifying issues that the parties believe ought to be resolved at the conference scheduled for Wednesday, October 18, 2017. The Court will therefore keep the October 18, 2017 conference in place, pending review of the parties' letter. However, in the light of the very limited advance notice that the parties' Monday letter will give the Court as to the issues to be resolved, the Court notifies the parties that it may prove necessary to adjourn the conference, to enable the Court to adequately prepare for the conference. The Court will make that assessment after reviewing counsels' letter. Separately, the Court directs counsel to be prepared for the October 18, 2017 conference to commence beginning at noon on October 18, 2017, rather than 2 p.m., as previously scheduled. The Court will notify counsel on Monday as to the start time of the conference. SO ORDERED. (Status Conference set for 10/18/2017 at 12:00 PM before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 10/13/2017)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 118
ORDER: A status conference in this case is scheduled for Wednesday, October 18, 2017. The Court is unaware of any open issues requiring its resolution at this time. The Court directs counsel to submit a joint letter due by noon on Monday, October 16, 2017 setting out the anticipated agenda of the conference. In the event that no party perceives a productive purpose for this conference, the Court would then adjourn the conference and schedule a next conference approximately one month later. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 10/12/2017)***Pursuant to instructions from Chambers, Filed In Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 117
ORDER NO. 14 (DEPOSITION PROTOCOL). ORDER RE: PROTOCOL GOVERNING FACT DEPOSITIONS: The parties have agreed upon the following Order governing the taking of depositions. This Order applies to all depositions of fact witnesses taken in cases pending in MDL No. 2767, which shall be noticed and conducted pursuant to the Federal Rules of Civil Procedure and this Order. This Order in its entirety shall be attached to any non-party subpoena or deposition notice. Although this Order governs all depositions noticed or cross-noticed in this MDL, the parties may stipulate to different arrangements. If one party believes that a particular deposition requires an exception from this protocol but the other party does not agree, the parties shall file a joint letter in accordance with the Court's previously described method for resolving discovery disputes; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 9/22/2017)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 116
ORDER re: (83 in 1:17-md-02767-PAE-JLC) Letter, filed by Bayer Oy, Bayer Pharma AG, Bayer Healthcare Pharmaceuticals Inc. The Court adjourns the conference that had been scheduled for Thursday, September 14, 2017 to Wednesday, October 18, 2017 at 2 p.m. The conference will be held in Courtroom 1305 at the Thurgood Marshall U.S. Courthouse, 40 Centre Street, New York, New York 10007. SO ORDERED. (Status Conference set for 10/18/2017 at 02:00 PM in Courtroom 1305, 40 Centre Street, New York, NY 10007 before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 9/11/2017)**Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 115
ORDER: The Court directs lead counsel to confer promptly and to notify the Court, by joint letter due at 5 p.m. on Friday, September 8, 2017, whether any party perceives a need for the conference and if so what the agenda for the conference would be. If no party believes the conference would be productive, the Court will adjourn the conference and set a next conference date for later in the autumn. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 9/7/2017) **Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 114
ORDER NO. 13: ORDER RESOLVING DISCOVERY DISPUTE: the Court directs that any non-privileged document yielded by application of the search terms that relates to, or mentions, in any way, either (1) Mirena or (2) IIH/PTC (whether by such name(s) or by an associated symptom or symptoms) be coded as relevant and produced. Defendants acknowledge their obligation to produce all such documents; and as further set forth herein. The Court will hold defendants to that commitment and expects the relevant review to occur contemporaneously with the privilege review and to be staffed sufficiently to guard against delay. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 9/6/2017) **Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 113
ORDER NO. 12 granting #32 Letter Motion for Discovery in case 17-mc-2767. ORDER REGARDING COMPLETION OF IH/PTC PLAINTIFF FACT SHEETS. Every Plaintiff is required to complete a Plaintiff Fact Sheet ("PFS"). The PFS includes document requests in Section XII and a variety of authorizations for the release of records. According to the schedule set forth in Part II below, each Plaintiff shall produce to Counsel for Defendants a completed PFS, executed Authorizations for the Release of Records ("Authorizations"), and documents responsive to Section XII of the PFS ("Responsive Documents"); and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 8/29/2017)**Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al. (anc)
|
|
Filing 112
ORDER NO. 11: Streamlined Service on Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG, and Bayer Oy. This Order applies to cases brought by a U.S. citizen or resident based on usage or purchase of MIRENA ("Mirena") within the United States in which the claimed injury is consistent with the Judicial Panel on Multidistrict Litigation's April 6, 2017 Transfer Order and (i) currently are pending in this centralized multidistrict litigation ("MDL No. 2767") or (ii) will be filed in, removed to or transferred to this MDL; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 8/29/2017) ***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc) Modified on 8/31/2017 (anc).
|
|
Filing 111
ORDER NO. 10 granting (67) Letter Motion for Discovery in case 1:17-md-02767-PAE-JLC. PROTOCOL FOR DOCUMENT PRODUCTION FORMAT. This Order governs the format of Documents, Data, and/or Tangible things that will be produced in this litigation. This Order does not govern the scope of production of Documents, Data, and/or Tangible things in the Litigation. All parties reserve their rights with respect to the scope of the document production; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 8/29/2017)**Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al. (anc) Modified on 8/31/2017 (anc).
|
|
Filing 110
ORDER granting (61) Letter Motion for Extension of Time to File Response/Reply in case 1:17-md-02767-PAE-JLC. The application is granted nunc pro tunc. (HEREBY ORDERED by Magistrate Judge James L. Cott)(Text Only Order) Filed In Associated Cases: 1:17-md-02767-PAE-JLC et al. (Cott, James)
|
|
Filing 109
ORDER: The next conference in this case will be held on September 14, 2017, at 10 am in Courtroom 1305 at the Thurgood Marshall U.S. Courthouse, 40 Centre Street, New York, New York 10007. SO ORDERED. (Status Conference set for 9/14/2017 at 10:00 AM in Courtroom 1305, 40 Centre Street, New York, NY 10007 before Judge Paul A. Engelmayer.) (Signed by Judge Paul A. Engelmayer on 7/28/2017)***Pursuant to instructions from Chambers, Filed In All Member Associated Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 108
ORDER NO. 9: The Court ordered the following: The Court ruled on and resolved the outstanding discovery disputes, identified in the parties' joint letter of June 30, 2017. See Dkt. 30. The Court set the following schedule for discovery, expert reports, and briefing on the issue of general causation and on the parties' anticipated Daubert motions as to evidence relating to general causation: December 8, 2017: Deadline for fact discovery relating to general causation; and as further set forth herein. SO ORDERED. (Deposition due by 2/16/2018. Discovery due by 1/31/2018. Fact Discovery due by 12/8/2017. Motions due by 2/23/2018. Responses due by 3/9/2018. Replies due by 3/23/2018.) (Signed by Judge Paul A. Engelmayer on 7/28/2017 and Signed by PAE for Magistrate Judge James L. Cott on 7/28/2017) ***Pursuant to instructions from Chambers, Filed In All Member Associated Cases: 1:17-md-02767-PAE-JLC et al.(anc) Modified on 7/31/2017 (anc).
|
|
Filing 107
CONFIDENTIALITY STIPULATION AND PROTECTIVE ORDER...regarding procedures to be followed that shall govern the handling of confidential material... (Signed by Judge Paul A. Engelmayer on 7/25/2017)***Pursuant to instructions from Chambers, Filed In All Member Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 106
ORDER REGARDING DOCUMENTS CLAIMED TO BE PRIVILEGED/PROTECTED granting (55) Letter Motion for Discovery in case 1:17-md-02767-PAE-JLC. This Order is entered to provide guidelines that govern claims the parties make to withhold information otherwise discoverable by claiming that the information is privileged/protected, the protocols that shall be followed with regard to privilege logs for documents fully withheld and those redacted for a claim of privilege ("privilege redactions"), and the method of determining privilege and/or privilege redaction disputes; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 7/25/2017) ***Pursuant to instructions from Chambers, Filed In All Member Associated Cases: 1:17-md-02767-PAE-JLC et al. (anc)
|
|
Filing 105
ORDER NO. 8: The Court accordingly directs counsel forthwith to work together collegially to complete the preparation of a plaintiffs' fact sheet consistent with these parameters, and to complete such a fact sheet, for submission to the Court by noon on Tuesday, July 25, 2017. The Court is hopeful that counsel will be able to resolve this assignment without the need for further judicial intervention. In the event, however, that differences remain among the parties as to particulars, the parties are to submit, by noon on Tuesday, July 25, 2017, a joint letter identifying each area of difference, and, alongside each, briefly setting forth each party's position. Along with this letter, counsel are to submit a draft of the fact sheet identifying, in redline, the parties' alternative formulations as to any disputed component(s). The Court's intention would be to take up at the July 27, 2017 conference, if necessary to facilitate its resolution, any open issues regarding the fact sheet. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 7/20/2017)***Pursuant to instructions from Chambers, Filed In All Associated Member Cases: 1:17-md-02767-PAE-JLC et al.(anc) Modified on 7/20/2017 (anc).
|
|
Filing 104
ORDER NO. 7: ORDER REGARDING RESPONSIBILITIES OF PLAINTIFFS' COUNSEL AND ADOPTION OF CASE MANAGEMENT PROTOCOLS. The Court hereby orders the following as to the responsibilities attendant to each position. Responsibilities of Plaintiffs' Counsel. Lead Counsel. In its June 16, 2017 Order (Doc. 37), the Court appointed plaintiffs' Lead Counsel and Liaison Counsel as follows: Lawrence L. Jones II (Jones Ward PLC) - Plaintiffs' Co-Lead Counsel; Martin Crump (Davis & Crump P.C.) - Plaintiffs' Co-Lead Counsel; Max Kennerly (Kennerly Loutey LLC) - Plaintiffs' Liaison Counsel. Lead Counsel will be responsible for prosecuting any potential common benefit claims, as well as coordinating the pretrial proceedings conducted by counsel for the individual plaintiffs; and as further set forth herein. The Court hereby adopts the following guidelines for the management of case-staffing, timekeeping, cost reimbursement, and related common benefit issues. The recovery of common benefit attorneys' fees and cost reimbursements will be limited to "Participating Counsel." "Participating Counsel" shall be defined as the members of the PEC and PSC (along with members and staff of their firm), any other counsel authorized by Lead Counsel who desire to be considered for common benefit compensation, or counsel who have been specifically approved by this Court as Participating Counsel prior to incurring any such cost or expense; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 6/27/2017) ***Pursuant to instructions from Chambers, filed In All Associated Cases: 1:17-md-02767-PAE-JLC et al.(anc)
|
|
Filing 103
ORDER REFERRING CASE TO MAGISTRATE JUDGE. Order that case be referred to the Clerk of Court for assignment to a Magistrate Judge for General Pretrial (includes scheduling, discovery, non-dispositive pretrial motions, and settlement). Referred to Magistrate Judge James L. Cott. (Signed by Judge Paul A. Engelmayer on 6/23/2017)***Pursuant to instructions from Chambers, Filed In all Associated and Related Cases: 1:17-md-02767-PAE et al.(anc) Modified on 6/23/2017 (anc).
|
|
Filing 102
ORDER NO. 6: IT IS HEREBY STIPULATED AND AGREED, by and between plaintiffs and defendants BAYER HEALTHCARE PHARMACEUTICALS INC., BAYER PHARMA AG and BAYER Oy (collectively "Bayer Defendants") through their respective counsel and subject to the approval of this Court, that the following Pro Tempore Order shall be entered in this MDL. To facilitate the immediate production of documents, the parties agree that the Protocol for Document Production Format, Order Regarding Documents Claimed to be Privileged/Protected, and Confidentiality Stipulation and Protective Order previously entered in MDL 2434 and attached hereto as Exhibits 1-3 shall be effective for the discovery conducted in MDL 2434 and prior IIH cases and will remain in effect for subsequent discovery unless the parties agree upon, or the Court enters without the parties' agreement, revised case management orders governing these subjects in this MDL; and as further set forth herein. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 6/21/2017) (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit) **Pursuant to instructions from Chambers, Filed In Associated and Related Cases: 1:17-md-02767-PAE et al.(anc) Modified on 6/22/2017 (anc).
|
|
Filing 101
ORDER NO. 5 - See Order. (Signed by Judge Paul A. Engelmayer & Magistrate Judge James L. Cott on 6/21/2017) Filed In Associated Cases: 1:17-md-02767-PAE et al.(ajs)
|
|
Filing 100
NOTICE OF APPEARANCE by Ernest Cory on behalf of Amanda Clark. Filed In Associated Cases: 1:17-md-02767-PAE et al.(Cory, Ernest)
|
|
Filing 99
NOTICE OF APPEARANCE by Elizabeth E Chambers on behalf of Amanda Clark. Filed In Associated Cases: 1:17-md-02767-PAE et al.(Chambers, Elizabeth)
|
|
Filing 98
ORDER NO. 4: ORDER REGARDING APPOINTMENTS TO PLAINTIFFS' LEADERSHIP POSITIONS: The Court hereby makes the following appointments. The Court appoints the following as plaintiffs' Co-Lead and Liaison Counsel: Lawrence L. Jones II(Jones Ward PLC): Plaintiffs' Co-Lead Counsel; Martin Crump (Davis & Crump P.C.): Plaintiffs' Co-Lead Counsel; Max Kennerly (Kennerly Loutey LLC): Plaintiffs' Liaison Counsel; and as further set forth herein. The Court directs plaintiffs' Co-Lead Counsel to file a proposed order setting out the specific responsibilities of each position and the protocols governing common benefit work. The Court expects that this order will substantially track, and cover all topics addressed in, Judge Seibel's order addressing these matters in Mirena I, Order No. 5, at 2-15 & Addendum A. This proposed order is due Monday, June 26, 2017. The Court directs plaintiffs' Co-Lead Counsel to confer with defendants' lead counsel by Thursday, June 22, 2017, about the text and terms of the proposed order, so as, ideally, to assure that the proposed order reflects all parties' views. Plaintiffs' June 26, 2017 submission is to state whether defendants agree to the proposed order; if defendants do not, they may submit a letter, due Wednesday, June 28, 2017, setting forth thier views and proposed modifications. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 6/16/2017) **As per Chambers, Filed In Associated and Related Cases: 1:17-md-02767-PAE et al.(anc)
|
|
Filing 97
NOTICE OF APPEARANCE by Nina T Herring on behalf of Amanda Clark. Filed In Associated Cases: 1:17-md-02767-PAE et al.(Herring, Nina)
|
|
Filing 96
ORDER REGARDING DIRECT FILING OF ACTIONS IN THE SOUTHERN DISTRICT OF NEW YORK: This Order applies to claims brought by a U.S. citizen or resident based on usage or purchase of MIRENA (levonorgestrel-releasing intrauterine system) within the United States in which the claimed injury is consistent with the Judicial Panel on Multidistrict Litigation's April 6, 2017 Transfer Order and (i) currently are pending in this centralized multidistrict litigation ("MDL No. 2767") or (ii) will be filed in, removed to or transferred to this Court (collectively, "the MDL Proceedings"). A. Any plaintiff whose case would be subject to transfer to MDL No. 2767 may file her case in the Southern District of New York ("this District") for pretrial proceedings only, consistent with the Judicial Panel on Multidistrict Litigation's April 6, 2017 Transfer Order. B. Defendants will not challenge venue as to any such action filed directly in this District. C. No Lexecon Waiver. For cases directly filed in this District, the Parties preserve and do not waive any and all rights under Lexecon Inc. v. Milberg Weiss, 523 U.S. 26 (1998) to have each case remanded to the district of traditional venue for trial. D. The direct filing of any action in this District, pursuant to this Order, shall have no impact on choice of law that otherwise would apply to an individual case had it been originally properly filed in another district and transferred to this Court pursuant to 28 U.S.C. 1407. E. The inclusion of any action in In Re: Mirena IUS Levonorgestrel-Related Products Liability Litigation (No. II), whether such action was originally filed in this District or elsewhere, shall not constitute a determination by this Court that jurisdiction or venue is proper in this District. F. Nothing in this Order shall preclude the parties from agreeing, at a future date, to try cases filed pursuant to this order in this District. G. Any complaint that is directly filed in this District for inclusion in MDL No. 2767 before this Court shall bear the following caption; as set forth herein. (Signed by Judge Paul A. Engelmayer on 6/15/2017) Filed In Associated Cases: 1:17-md-02767-PAE et al.(mro) Modified on 6/16/2017 (mro).
|
|
Filing 95
ORDER NO. 2: In the event that counsel for any plaintiff has a well-founded concern that the "Mirena Preservation Order" approved by Judge Seibel leaves or may leave at risk of non-preservation relevant information in defendants' custody or control, such counsel are to communicate this concern to Temporary Plaintiffs' Counsel, who in turn are communicate it promptly in writing to defendants' Lead Counsel. The Court expects that defense counsel, in turn, will consider promptly and in good faith any proposal for expansion of defendants' preservation obligations. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 5/12/2017) Filed In Associated Cases: 1:17-md-02767-PAE et al.(anc)
|
|
Filing 94
ORDER NO. 1: Please see Order. The Court (joined by the Hon. James L. Cott, the Magistrate Judge assigned to this MDL) will conduct an Initial Conference on June 13, 2017, at 10 a.m., in Courtroom 318 at the Thurgood Marshall Courthouse, 40 Centre Street, New York, New York. (Please note that this is not Judge Engelmayer's regular courtroom.) Counsel shall check in with the Courtroom Deputy at least 15 minutes in advance, and as further specified and set forth in this Order. (Initial Conference set for 6/13/2017 at 10:00 AM, Courtroom 318, U.S. Courthouse, before Judge Paul A. Engelmayer). (Signed by Judge Paul A. Engelmayer on 4/25/2017) Filed In Associated Cases: 1:17-md-02767-PAE et al. Entry in cases as per Chambers. Notified MDL Clerk. (rjm).
|
|
Filing 93
MDL TRANSFERRED IN from the United States District Court - District of Tennessee Eastern; Case Number: 3:15-cv-00137. Original file certified copy of transfer order and docket entries received. (sjo)
|
|
CONSOLIDATED MDL CASE: Create association to 1:17-md-02767-PAE. (sjo)
|
|
CASE ACCEPTED AS RELATED. Create association to 1:17-md-02767-PAE. (sjo)
|
|
Magistrate Judge James L. Cott is so designated. (sjo)
|
|
CASE OPENING INITIAL ASSIGNMENT NOTICE - TRANSFER CASE: This case is assigned to: Judge Paul A. Engelmayer. Please download and review the Individual Practices of the assigned District Judge, located at #http://nysd.uscourts.gov/judges/District. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #http://nysd.uscourts.gov/ecf_filing.php. (sjo)
|
|
NOTE TO OUT OF STATE ATTORNEYS: Please visit the Court's website at http://www.nysd.uscourts.gov for information regarding admission to the S.D.N.Y. Bar and the CM/ECF Rules & Filing Instructions. (sjo)
|
|
Case Designated ECF. (sjo)
|
|
Filing 92
UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION TRANSFER ORDER IN RE: MIRENA IUS LEVONORGESTREL-RELATED PRODUCTS LIABILITY LITIGATION (NO. II) (MDL No. 2767) transferring this action to the Southern District of New York. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Case electronically transferred to the Southern District of New York. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 91
REPLY to Response to Motion re #85 MOTION Certification of Novel Question of State Law to the Supreme Court of Tennessee filed by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 90
NOTICE of Change of Address by Lawrence L Jones, II (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 89
RESPONSE in Opposition re #85 MOTION Certification of Novel Question of State Law to the Supreme Court of Tennessee filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 88
Minute Entry for proceedings held before Magistrate Judge H Bruce Guyton: DAUBERT HEARING held on 3/8/2017. Arugments heard. Court took matter under advisement. Order to enter.(Court Reporter ECRO Recording) (MDG) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 87
ORDER granting #80 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php. Signed by Magistrate Judge H. Bruce Guyton on 3/8/2017. (This entry constitutes the complete Order of the Court.) (AGA) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 86
MEMORANDUM in Support of Motion re #85 MOTION Certification of Novel Question of State Law to the Supreme Court of Tennessee filed by Abra L. Coning. (Attachments: #1 Exhibit Exhibit 1 Part 1, #2 Exhibit Exhibit 1 Part 2, #3 Exhibit Exhibits 2 and 3, #4 Exhibit Exhibit 4, #5 Exhibit Exhibit 5)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 85
MOTION Certification of Novel Question of State Law to the Supreme Court of Tennessee by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding #80 MOTION for Leave to Appear Pro Hac Vice of Christina Teresa Natale (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing fee for #80 pro hac vice motion of Christina Natale in the amount of $ 90 (receipt number K3032586) received from Jones Ward PLC (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 84
ORDER granting #81 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php. Signed by Magistrate Judge H. Bruce Guyton on 3/3/2017. (This entry constitutes the complete Order of the Court.) (AGA) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 83
SUPPLEMENT to #33 NOTICE of Filing List of Evidentiary Materials Relied upon to Support #31 Omnibus MOTION to Exclude General Causation and Labeling Opinions of Plaintiff's Experts by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 56, #2 Exhibit 57) (Evans, Matthew) Modified text on 3/6/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 82
NOTICE of Filing of Exhibit Attachment by Abra L. Coning to #65 Response to Statement of Material Facts (Attachments: #1 Exhibit) (Jones, Lawrence) Modified text on 3/3/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding #81 MOTION for Leave to Appear Pro Hac Vice as to Michael X. Imbroscio (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 81
MOTION for Leave to Appear Pro Hac Vice as to Michael X. Imbroscio ( Filing fee $ 90 receipt number 0649-3337237.) by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Other Certificate of Good Standing)(Fiala, Jacquelyne) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 80
MOTION for Leave to Appear Pro Hac Vice Christina Teresa Natale (Filing fee $ 90 is being forwarded to the Clerk's Office by counsel) by Abra L. Coning. (Attachments: #1 Exhibit) (Natale, Christina) Modified text on 3/2/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 79
ORDER denying #70 Plaintiff's Motion to Stay March 8th Hearing. Signed by Magistrate Judge H Bruce Guyton on February 23, 2017. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 78
REPLY to Response to Motion re #70 MOTION to Stay re Notice of Hearing filed by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 77
REPLY to Response to Motion re #48 MOTION to Exclude the Opinions of Defendants' Expert OBGYNs filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 76
REPLY to Response to Motion re #50 MOTION to Exclude the Opinions of Defendants' Expert Epidemiologists filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 75
REPLY to Response to Motion re #52 MOTION to Exclude the Opinions of Defendants' Expert Pharmacologist filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 74
REPLY to Response to Motion re #57 Amended MOTION to Exclude Testimony of Defendants' Regulatory Experts re #54 MOTION to Exclude the Opinions of Defendants' Regulatory Experts filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 73
RESPONSE in Opposition re #70 MOTION to Stay re Notice of Hearing filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 72
REPLY to Response to Motion re #41 MOTION for Summary Judgment filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 45, #2 Exhibit 46, #3 Exhibit 47, #4 Exhibit 48, #5 Exhibit 49, #6 Exhibit 50, #7 Exhibit 51)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 71
REPLY MEMORANDUM in Support of #41 Defendants' MOTION for Summary Judgment filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) Modified text on 2/21/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 70
MOTION to Stay re Notice of Hearing by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 69
RESPONSE in Opposition re #50 MOTION to Exclude the Opinions of Defendants' Expert Epidemiologists filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 68
RESPONSE in Opposition re #57 Amended MOTION to Exclude Testimony of Defendants' Regulatory Experts re #54 MOTION to Exclude the Opinions of Defendants' Regulatory Experts filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 67
RESPONSE in Opposition re #52 MOTION to Exclude the Opinions of Defendants' Expert Pharmacologist filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 66
RESPONSE in Opposition re #48 MOTION to Exclude the Opinions of Defendants' Expert OBGYNs filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 65
RESPONSE to Statement of Material Facts re #45 Statement of Material Facts filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit, #12 Exhibit, #13 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 64
RESPONSE in Opposition re #41 MOTION for Summary Judgment filed by Abra L. Coning. (Attachments: #1 Exhibit Ex 1, #2 Exhibit Ex 2, #3 Exhibit Ex 3, #4 Exhibit Ex 4, #5 Exhibit Ex 5, #6 Exhibit Ex 6, #7 Exhibit Ex 7a, #8 Exhibit Ex 7b, #9 Exhibit Ex 7c, #10 Exhibit Ex 8, #11 Exhibit Ex 9, #12 Exhibit Ex 10, #13 Exhibit Ex 11, #14 Exhibit Ex 12, #15 Exhibit Ex 13, #16 Exhibit Ex 14, #17 Exhibit Ex 15, #18 Exhibit Ex 16, #19 Exhibit Ex 17, #20 Exhibit Ex 18, #21 Exhibit Ex 19, #22 Exhibit Ex 20, #23 Exhibit Ex 21, #24 Exhibit Ex 22, #25 Exhibit Ex 23, #26 Exhibit Ex 24, #27 Exhibit Ex 25, #28 Exhibit Ex 26, #29 Exhibit Ex 27, #30 Exhibit Ex 28, #31 Exhibit Ex 29, #32 Exhibit Ex 30, #33 Exhibit Ex 31, #34 Exhibit Ex 32)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 63
REPLY to Response to Motion re #34 MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Exhibit 1)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 62
REPLY to Response to Motion re #31 MOTION Omnibus to Exclude General Causation and Labeling Opinions of Plaintiff's Experts filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 61
AMENDED RESPONSE in Opposition re #34 MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH by Abra L. Coning. Amendment to #60 Response in Opposition to Motion, . (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit) (Jones, Lawrence) Modified text on 2/6/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 60
RESPONSE in Opposition re #34 MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 59
RESPONSE in Opposition re #31 MOTION Omnibus to Exclude General Causation and Labeling Opinions of Plaintiff's Experts filed by Abra L. Coning. (Attachments: #1 Appendix, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit, #12 Exhibit, #13 Exhibit, #14 Exhibit, #15 Exhibit, #16 Exhibit, #17 Exhibit, #18 Exhibit, #19 Exhibit, #20 Exhibit, #21 Exhibit, #22 Exhibit, #23 Exhibit, #24 Exhibit, #25 Exhibit, #26 Exhibit, #27 Exhibit, #28 Exhibit, #29 Exhibit, #30 Exhibit, #31 Exhibit, #32 Exhibit, #33 Exhibit, #34 Exhibit, #35 Exhibit, #36 Exhibit, #37 Exhibit, #38 Exhibit, #39 Exhibit, #40 Exhibit, #41 Exhibit, #42 Exhibit, #43 Exhibit, #44 Exhibit, #45 Exhibit, #46 Exhibit, #47 Exhibit, #48 Exhibit, #49 Exhibit, #50 Exhibit, #51 Exhibit, #52 Exhibit, #53 Exhibit, #54 Exhibit, #55 Exhibit, #56 Exhibit, #57 Exhibit, #58 Exhibit, #59 Exhibit, #60 Exhibit, #61 Exhibit, #62 Exhibit, #63 Exhibit, #64 Exhibit, #65 Exhibit, #66 Exhibit, #67 Exhibit, #68 Exhibit, #69 Exhibit, #70 Exhibit, #71 Exhibit, #72 Exhibit, #73 Exhibit, #74 Exhibit, #75 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 58
MEMORANDUM in Support of Motion re #57 Amended MOTION to Exclude Testimony of Defendants' Regulatory Experts re #54 MOTION to Exclude the Opinions of Defendants' Regulatory Experts filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 57
Amended MOTION to Exclude Testimony of Defendants' Regulatory Experts re #54 MOTION to Exclude the Opinions of Defendants' Regulatory Experts by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 56
Certificate of Corporate Interest by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG identifying Corporate Parent Bayer AG for Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Fiala, Jacquelyne) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 55
Administrative Notice to Counsel re #54 MOTION to Exclude the Opinions of Defendants' Regulatory Experts: document attached is the Memorandum in Support of this Motion. Please file the correct documents with the correct ECF events. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 54
**DISREGARD - Plaintiff has refiled correct document as Doc. #57 - MOTION to Exclude the Opinions of Defendants' Regulatory Experts by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit)(Jones, Lawrence) Modified on 2/3/2017 to term as a motion (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 53
MEMORANDUM in Support of Motion re #52 MOTION to Exclude the Opinions of Defendants' Expert Pharmacologist filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 52
MOTION to Exclude the Opinions of Defendants' Expert Pharmacologist by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 51
MEMORANDUM in Support of Motion re #50 MOTION to Exclude the Opinions of Defendants' Expert Epidemiologists filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 50
MOTION to Exclude the Opinions of Defendants' Expert Epidemiologists by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 49
MEMORANDUM in Support of Motion re #48 MOTION to Exclude the Opinions of Defendants' Expert OBGYNs filed by Abra L. Coning. (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit, #7 Exhibit, #8 Exhibit, #9 Exhibit, #10 Exhibit, #11 Exhibit, #12 Exhibit, #13 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 48
MOTION to Exclude the Opinions of Defendants' Expert OBGYNs by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
NOTICE of Hearing: Motion Hearing set for 3/8/2017 09:30 AM in Courtroom 3A - Knoxville before Magistrate Judge H Bruce Guyton to address all Daubert Motions. (MDG) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 47
ORDER granting #44 Plaintiff's Uncontested Motion for Extension of Deadline for Motions for Daubert Hearing. Signed by Magistrate Judge H. Bruce Guyton on 1/24/2017. (This entry constitutes the complete Order of the Court.) (AGA) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 46
ORDER granting #27 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php. Signed by Magistrate Judge H. Bruce Guyton on 1/23/2017. (This entry constitutes the complete Order of the Court.) (AGA) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 45
STATEMENT of Material Facts re #41 MOTION for Summary Judgment filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Martin, Lindsey) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 44
MOTION for Extension of Time to File Motions for Daubert Hearing by Abra L. Coning. (Attachments: #1 Exhibit)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 43
NOTICE by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG of Filing List of Evidentiary Materials Relied Upon in Support of #41 MOTION for Summary Judgment (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44)(Evans, Matthew) Modified text on 1/23/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 42
MEMORANDUM in Support of Motion re #41 MOTION for Summary Judgment filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 41
MOTION for Summary Judgment by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 40
AMENDED #32 Memorandum in Support of Motion by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) Modified text on 1/23/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 39
JOINT MEDIATION STATEMENT by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG (Evans, Matthew) Modified text on 1/20/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 38
NOTICE of Request for Oral Argument by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG re #34 MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH and #31 MOTION Omnibus to Exclude General Causation and Labeling Opinions of Plaintiff's Experts (Evans, Matthew) Modified text on 1/20/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 37
Certificate of Good Standing - Northern District of Illinois re: #27 MOTION for Leave to Appear Pro Hac Vice of Shayna Susanne Cook by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Fiala, Jacquelyne) Modified text on 1/20/2017 (AYB). [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 36
NOTICE by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG re #34 MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH of Filing List of Evidentiary Materials Relied Upon to Support (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 35
MEMORANDUM in Support of Motion re #34 MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 34
MOTION to Exclude Specific Causation Expert Testimony of Axel Rosengart, M.D., Ph.D., MPH by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 33
NOTICE by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG re #31 MOTION Omnibus to Exclude General Causation and Labeling Opinions of Plaintiff's Experts of Filing List of Evidentiary Materials Relied upon to Support (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52, #53 Exhibit 53, #54 Exhibit 54, #55 Exhibit 55)(Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 32
MEMORANDUM in Support of Motion re #31 MOTION Omnibus to Exclude General Causation and Labeling Opinions of Plaintiff's Experts filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 31
MOTION Omnibus to Exclude General Causation and Labeling Opinions of Plaintiff's Experts by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 30
NOTICE of Deficiency (Pro Hac) re: #27 MOTION for Leave to Appear Pro Hac Vice of Shayna Susanne Cook. A certificate of good standing from another district court must be submitted. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding #27 MOTION for Leave to Appear Pro Hac Vice of Shayna Susanne Cook (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 29
NOTICE of Appearance by Lindsey Martin on behalf of Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG (Martin, Lindsey) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 28
NOTICE of Appearance by Matthew J Evans on behalf of Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG (Evans, Matthew) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding #27 MOTION for Leave to Appear Pro Hac Vice of Shayna Susanne Cook (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 27
MOTION for Leave to Appear Pro Hac Vice of Shayna Susanne Cook ( Filing fee $ 90 receipt number 0649-3301236.) by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Other Certificate of Good Standing)(Fiala, Jacquelyne) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 26
ORDER granting #25 Unopposed Motion for Leave to File an Omnibus Daubert Motion in Excess of Twenty-Five Pages. Signed by Magistrate Judge H. Bruce Guyton on 1/13/2017. (This entry constitutes the complete Order of the Court.) (AGA) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 25
Unopposed MOTION for Leave to File An Omnibus Daubert Motion In Excess of Twenty-Five Pages by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Doran, James) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Courtesy copy of "Plaintiffs' Motion for Transfer of Actions to the USDC for the Southern District of Mississippi Pursuant to 28:1407 for Coordinated Pretrial Proceedings" (filed in the MDL) received in the Clerk's Office. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 24
ORDER granting #21 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php; granting #22 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php; granting #23 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php. Signed by Magistrate Judge H. Bruce Guyton on 12/8/2016. (This entry constitutes the complete Order of the Court.) (AGA) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding #23 MOTION for Leave to Appear Pro Hac Vice of Paul W. Schmidt (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 23
MOTION for Leave to Appear Pro Hac Vice - Paul W. Schmidt ( Filing fee $ 90 receipt number 0649-3272173.) by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Other Certificate of Good Standing)(Fiala, Jacquelyne) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding #22 MOTION for Leave to Appear Pro Hac Vice of Amy J. Roy and #21 MOTION for Leave to Appear Pro Hac Vice of Wendy West Feinstein (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 22
MOTION for Leave to Appear Pro Hac Vice - Amy J. Roy ( Filing fee $ 90 receipt number 0649-3270739.) by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Other Certificate of Good Standing)(Fiala, Jacquelyne) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 21
MOTION for Leave to Appear Pro Hac Vice - Wendy West Feinstein ( Filing fee $ 90 receipt number 0649-3270732.) by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Other Certificate of Good Standing)(Fiala, Jacquelyne) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 20
CONFIDENTIALITY STIPULATION AND PROTECTIVE ORDER. Signed by District Judge Pamela L Reeves on April 27, 2016. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 19
Joint MOTION for Protective Order (For Entry of Agreed Protective Order) by Bayer Healthcare Pharmaceuticals Inc.. (Attachments: #1 Other Confidentiality Stipulation and Protective Order)(Doran, James) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 18
ORDER granting #17 the parties' joint motion to continue the trial scheduled for November 29, 2016. The trial of this case is continued and shall commence on June 20, 2017 at 9:00 AM in Courtroom 3C - Knoxville before District Judge Pamela L Reeves. Signed by District Judge Pamela L Reeves on April 12, 2016. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 17
First MOTION to Amend/Revise filed Jointly by Abra L. Coning. (Attachments: #1 Other Proposed Order)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 16
AFFIDAVIT of Service for Complaint and Jury Demand/Civil Summons served on Bayer Pharma AG on 10/2/2015, filed by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 15
Order Governing Depositions. Signed by District Judge Pamela L Reeves on December 2, 2015. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 14
SCHEDULING ORDER: Jury Trial set for 11/29/2016 at 9:00 AM in Courtroom 3C - Knoxville before District Judge Pamela L Reeves. Signed by District Judge Pamela L Reeves on December 2, 2015. (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 13
NOTICE OF NONCONSENT TO MAGISTRATE by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG (Doran, James) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 12
ORDER: The parties are ordered to confer and return the attached form within the time provided. Signed by District Judge Pamela L Reeves on October 22, 2015. (Attachments: #1 Other Notice of Consent/Non-Consent to Magistrate) (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 11
Defendants' Original Global ANSWER to #1 Complaint, by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG.(Doran, James) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 10
AFFIDAVIT of Service for Complaint and Jury Demand/Civil Summons served on Bayer OY/Juhani Syrjala on 09/29/2015, filed by Abra L. Coning. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 9
ORDER granting #8 Motion for Extension of Time to Answer. Signed by Magistrate Judge H Bruce Guyton on 5/28/15. (JBR) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 8
MOTION for Extension of Time to File Answer re #1 Complaint, by Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Other Proposed Order)(Doran, James) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 7
WAIVER OF SERVICE Returned Executed by Abra L. Coning. Bayer Healthcare Pharmaceuticals Inc. waiver sent on 3/30/2015. (Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 6
Summons Reissued as to Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, Bayer Pharma AG. (Attachments: #1 Summons Bayer OY, #2 Summons Bayer Pharma AG) (AYB) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 5
ORDER granting #2 Motion for Leave to Appear Pro Hac Vice. You MUST register as a CM/ECF user here: #http://www.tned.uscourts.gov/RegistrationForm.php. Signed by Magistrate Judge H. Bruce Guyton on 03/30/2015. This entry constitutes the complete order of the Court. There is no document attached to this entry. (REM) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 4
NOTICE by Abra L. Coning re #3 Summons Issued (Attachments: #1 Summons Revised - BHCP, #2 Summons Revised - Bayer Oy, #3 Summons Revised - Bayer Pharma AG)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 3
Summons Issued as to Bayer Healthcare Pharmaceuticals Inc., Bayer Oy, and Bayer Pharma AG. (Attachments: #1 Summons Bayer Pharma AG, #2 Summons Bayer Healthcare Pharmaceuticals Inc) (AMP) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 2
MOTION for Leave to Appear Pro Hac Vice for Attorney Lawrence L. Jones, II ( Filing fee $ 90 receipt number 0649-2785114.) by Abra L. Coning. (Attachments: #1 Other Certificate of Good Standing - Western District of Kentucky)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Filing 1
COMPLAINT and Jury Demand against All Defendants ( Filing fee $ 400 receipt number 0649-2785082.), filed by Abra L. Coning. (Attachments: #1 Other Civil Case Cover Sheet, #2 Summons Summons for Bayer Oy, #3 Summons Summons for Bayer Pharma AG, #4 Summons Summons for Bayer Healthcare Pharmaceuticals Inc.)(Jones, Lawrence) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
Clerk's Verification of PHV Requirements is complete regarding document: #2 MOTION for Leave to Appear Pro Hac Vice for Attorney Lawrence L. Jones, II ( Filing fee $ 90 receipt number 0649-2785114.) filed by Abra L. Coning (AMP) [Transferred from Tennessee Eastern on 4/13/2017.]
|
|
District Judge Pamela L Reeves and Magistrate Judge H Bruce Guyton added. (AMP) [Transferred from Tennessee Eastern on 4/13/2017.]
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
